1. Abraham, J. and Klagsbrun, M. (1995) The role of the fibroblast growth factor family in wouldhealing. In: R.A. Clark (ed): The Molecular and Cellular Biology of Wound Repair. Plenum Press, New York, pp 195–248.
2. Antonelli-Orlidge, A., Saunder, K.B., Smith, S.R. and D’Amore, P.A. (1989) An activated formof transforming growth factor beta is produced by co-cultures of endothelial cells and pericytes. Proc. Nad. Acad. Sci. USA 86:4544–4548.
3. Bouck, N. (1990) Tumor angiogenesis: The role of oncogenes and tumor suppressor genes.Cancer Cells 2:180–185.
4. Cao, Y., Chen, H., Zhou, L., Chiang, M.-K., Anand-Apte, B., Weatherbee, J.A., Wang, Y, Fang, F., Flanagan, J.G. and Tsang, M.L.-S. (1996) Heterodimers of placenta growth factor/vascular endothelial growth factor. J. Biol. Chem. 271:3154–3162.
5. Clapp, C, Martial, J.A., Guzman, R.C., Rentier-Delure, F. and Weiner, R.I. (1993) The 16-kilo-dalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.Endocrinology 133:1292–1299.